Cardiac Insight Inc.
Bellevue, US · 4 known investors
Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
Founders & leadership
BW
Bill WillisExecutive Officer
HR
Hemanth ReddyDirector
BH
Brad HarlowExecutive Officer, Director
RM
Richard MartinDirector
RD
Robert deGavreExecutive Officer, Director
DL
David LinkerExecutive Officer, Director
LG
Lex GambleDirector
MS
Mike SchuhExecutive Officer
BO
Bob OdellExecutive Officer
RH
Robert HauserDirector
KC
Kirby CramerDirector
DD
Dr. Dave HadleyFounder
Investors · 4
Reported raises · per SEC filings
Form D private placements▶$11.6MraisedMar 2022 · 6 investors · Other Health CareRule 506(b)
▶$11.6MraisedMar 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Hyoung Min KimExecutive Officer, Director
- Michael SchuhExecutive Officer
- Robert OdellExecutive Officer
- Ann DemareeExecutive Officer
- David HadleyExecutive Officer
- Daniel TylutkiExecutive Officer
- Stacy SprouseExecutive Officer
- Kurt NoltensmeyerExecutive Officer
- Offering amount
- $12.1M
- Amount sold
- $11.6M
- Minimum investment
- $20K
- First sale
- Mar 2022
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$4.7MraisedAug 2019 · 12 investors · BiotechnologyRule 506(b)
▶$4.7MraisedAug 2019 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard MartinDirector
- Bob OdellExecutive Officer
- Mike SchuhExecutive Officer
- Brad HarlowExecutive Officer, Director
- Kirby CramerDirector
- Robert deGavreDirector
- Clifford StocksDirector
- Offering amount
- $11.8M
- Amount sold
- $4.7M
- First sale
- Jul 2019
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$2.8MraisedAug 2017 · 31 investors · BiotechnologyRule 506(b)
▶$2.8MraisedAug 2017 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert deGavreDirector
- Bob OdellExecutive Officer
- Kirby CramerDirector
- Mike SchuhExecutive Officer
- Tom ClementDirector
- Brad HarlowExecutive Officer, Director
- Robert HauserDirector
- Richard MartinDirector
- Lex GambleDirector
- Bill WillisExecutive Officer
- Offering amount
- $10M
- Amount sold
- $2.8M
- First sale
- May 2017
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$1MraisedDec 2016 · 1 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David LinkerExecutive Officer, Director
- Brad HarlowExecutive Officer, Director
- Lex GambleDirector
- Kirby CramerDirector
- Tom ClementDirector
- Bob OdellExecutive Officer
- Bill WillisExecutive Officer
- Mike SchuhExecutive Officer
- Hemanth ReddyDirector
- Robert deGavreDirector
- Richard MartinDirector
- Robert HauserDirector
- Offering amount
- $2.4M
- Amount sold
- $1M
- First sale
- Nov 2016
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$2.5MraisedApr 2016 · 30 investors · BiotechnologyRule 506(b)
▶$2.5MraisedApr 2016 · 30 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David LinkerExecutive Officer, Director
- Mike SchuhExecutive Officer
- Kirby CramerDirector
- Bob OdellExecutive Officer
- Hemanth ReddyDirector
- Robert deGavreDirector
- Tom ClementDirector
- Richard MartinDirector
- Robert HauserDirector
- Brad HarlowExecutive Officer, Director
- Lex GambleDirector
- Bill WillisExecutive Officer
- Offering amount
- $5M
- Amount sold
- $2.5M
- First sale
- Apr 2016
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.5MraisedSep 2015 · 2 investors · BiotechnologyRule 506(b)
▶$3.5MraisedSep 2015 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bill WillisExecutive Officer
- Hemanth ReddyDirector
- Tom ClementDirector
- Brad HarlowExecutive Officer, Director
- Richard MartinDirector
- Robert deGavreExecutive Officer, Director
- David LinkerExecutive Officer, Director
- Lex GambleDirector
- Mike SchuhExecutive Officer
- Bob OdellExecutive Officer
- Robert HauserDirector
- Kirby CramerDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- First sale
- Sep 2015
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.